Skip to main content
. Author manuscript; available in PMC: 2011 Jul 24.
Published in final edited form as: Neuroimage. 2009 Jul 1;48(2):391–397. doi: 10.1016/j.neuroimage.2009.06.062

Table 1.

Clinical characteristics of the research participants (Mean ± SEM)

METH Exposed
(n=49)
Un-exposed
(n=49)
p-value
Characteristics of the children
# of children (% males / % females) 30(61%)/19(39%) 27(55%)/22(45%) 0.54
Age (months) 46.90 ± 1.07 45.17 ± 0.99 0.24
Current Height (cm) 98.11 ± 0.91 100.06 ± 0.90 0.13
Current Weight (kg) 16.42 ± 0.40 17.24 ± 0.41 0.16
Current Head Circumference (cm) 50.37 ± 0.21 50.63 ± 0.18 0.34
Gestational age at birth (wks) 38.74 ± 0.23 39.47 ± 0.18 0.01
Activity, Pulse, Grimace, Appearance, and Respiration (APGAR) score at 5 min 8.86 ± 0.08 9.03 ± 0.05 0.07
Birth weight (kg) 3.10 ± 0.11 3.48 ± 0.07 0.003
Birth length (cm) 49.58 ± 0.45 50.94 ± 0.97 0.22
Maternal age and drug exposure
Age at time of child's birth (yrs) 24.53 ± 0.99 26.06 ± 0.96 0.27
#Trimesters used METH 2.42 ± 0.14 0
#Trimesters used alcohol 0.85 ± 0.21 0.21 ± 0.08 0.002
#Trimesters used nicotine cigarettes 2.05 ± 0.21 0.67 ± 0.17 <0.0001
#Trimesters used marijuana 1.00 ± 0.22 0.12 ± 0.07 <0.0001